Resverlogix appoints Cann as CFO

Resverlogix (TSX:RVX) has named A. Brad Cann as chief financial officer, effective Oct. 26, replacing Kelly McNeill, who will be nominated as a corporate director at the company’s annual meeting this Thursday.

Mr. Cann was previously executive vice president and CFO of Royal Host Real Estate Investment Trust.

Donald McCaffrey, CEO of Calgary-based Resverlogix, said in a press release that Mr. Cann will round out the “collective expertise within Resverlogix, including developing strategic initiatives, securing financings for publicly traded companies and he is a chartered business valuator.”  The company, which recently traded at $2.79, is developing an oral, small molecule drug to treat atherosclerosis and other diseases such as acute coronary syndrome, diabetes, Alzheimer’s, peripheral artery disease and other vascular disorders.